Aptose Biosciences Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
US Stock Market Weekly Review Dec. 7- 11, 2020
Article By: Stavros Georgiadis
Sunday, December 13, 2020 7:27 AM EDT
The Non-farm Productivity for Q3 2020 came in at weaker than expected with 4.6%, less than the consensus of 5.0%. This figure reflects the broader business health and economic growth.
In this article: GLBS, ONCY, MEGH, APTO, SFIX, TPGY-UN Also: PFE, BNTX
Read
Week In Review: Mevion Medical Of Boston Closes $150 Million Financing From China Investors
Article By: ChinaBio® Today
Saturday, June 16, 2018 4:07 PM EDT
Mevion Medical Systems, a Boston area maker of proton therapy machines, closed a $150 million financing led by YuanMing Capital with participation by other China-based private equity investors.
In this article: APTO, BMY, TTPH
Read
Here's A Look At The Drug That Underpins The Latest Aptose Biosciences Inc. Designation
Article By: Samuel Rae
Friday, January 5, 2018 11:44 AM EDT
Aptose Biosciences Inc. picked up Orphan Designation for an early stage development asset on Dec 26, 2017. Here's a look at what that means.
In this article: APTO
Read
All Posts

Latest Tweets for $APTO

No tweets yet!

PARTNER HEADLINES